Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
The Mechanobiology Institute at the National University of Singapore has recently secured S million in funding from the National Research Foundation to promote research aimed at advancing the field of mechanobiology
PRISM BioLab Co Ltd a leading discovery and development biotechnology company designing small molecule inhibitors of proteinprotein interaction targets today announced a billion yen fundraise Funds will be used to refine PRISMs
Beijingbased Biocytogen Pharmaceuticals Co Ltd has launched a new subbrand representing its antibody discovery business division We are pleased to announce the launch of RenBiologics RenBiologics operations
Biosion USA Inc a global clinicalstage RD biotechnology company today announced that the US Food and Drug Administration has cleared its Investigational New Drug application for BSI a novel antiSIRP monoclonal antibody
Sirnaomics Ltd a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics announced today the Company published a research article
Harbour BioMed announced that the Company has been granted the clearance of Investigational New Drug from the Food and Drug Administration of the United States to initiate the firstinhuman clinical trial in the US for bispecific antibody HBM This is...
WuXi XDC a leading global Contract Research Development and Manufacturing Organization focused on ADC and the other types of bioconjugate market and Celltrion Inc a leading global biopharmaceutical
InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases announced today that the first pediatric patient has been dosed in clinical trial
Bold Therapeutics a clinicalstage biopharmaceutical company developing novel metallotherapeutics presented positive Phase safety and efficacy data in advanced metastatic colorectal cancer
Gannex Pharma Company Ltd a whollyowned company of Ascletis Pharma Inc announced that its strategic partner Sagimet Biosciences Inc today reported positive topline results from Sagimets
